Thanks, Hazel. Great to see the message is starting to seep through. And thanks also for your own great efforts.
But I must say, the Gilead response was a bit thin.
"A spokeswoman for Gilead said the company would negotiate on price if asked. 'We remain ready and willing to continue discussions with the government and NHS England in the public interest and in a constructive manner,' she told Good Health."
Still, this is a big step forward from the usual "not available for comment", and it almost seems like Gilead is accepting that the ball is now in the NHS court.
Dear NHS, what are you waiting for? Don't you read the news in France?
Diagnosed Jan 2015: GT3, A0+F0/F1. Fatigue + Brain-Fog.
Started Sof+Dac from fixHepC 10-Nov-2015. NO sides.
Pre-Tx: AST 82, ALT 133, Viral Load 1 900 000.
Week4: AST 47, ALT 58. VL < 15 (unquantifiable).
Week12 (EOT): AST 30, ALT 26, VL UND
Week16 (EOT+4): AST 32, ALT 28, GGT 24, VL UND
Week28 (EOT+16): AST 26, ALT 22, GGT 24, VL UND
Ever grateful to Dr James.
Relapsed somewhere after all that... Bummer!
Jan 2018: VL 63 000 (still GT3).